🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients

RecruitingNAAges 18 Years - 75 YearsAllPetrovsky National Research Centre of Surgery
NCT06336213 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

According to the literature, presepsin was recommended not only as an effective indicator in the diagnosis of sepsis in intensive care units, but also as a reliable prognostic marker of postoperative inflammatory processes in cardiac surgery. Previous study carried out in Petrovsky NRCS related to biomarkers in cardiac surgery and presepsin in particular showed good sensitivity in infection complications prognosis.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Thoracic aorta aneurysm/dissection Exclusion Criteria: Blood sample hemolysis
💊

What it tests

  • Ampicillin-sulbactam
📍

Where

1 site
Petrovsky Research National Centre of Surgery (Petrovsky NRCS)
Moscow, Russia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy